Abstract
To assess the immediate therapeutic clinical efficacy and long-term outcome, hyperthermia in combination with irradiation or chemotherapeutic agent was used in 46 patients with invasive bladder cancer. Radiohyperthermia (RH) was employed in 19 cases and chemohyperthermia (CH) in 27 cases. Complete response (CR) was obtained in 5 and partial response (PR) in 15 of the 46 cases. One-year survival rates by the Kaplan-Meier method were 65.0% in the CR/PR group and 46.2% in the no change (NC)/progressive disease (PD) group. Five-year survival rates were 43.8% and 18.3%, showing no difference in survival rate between the CR/PR group and the CN/PD group. The overal median survival period for the CR/PR group without metastasis was 61.6 months compared to 32.3 months for the NC/PD group without metastasis (P<0.05).
Similar content being viewed by others
References
Kubota, Y., Shuin, T., Miura, T., Nishimura, R.: Treatment of bladder cancer with a combination of hyperthermia, radiation and bleomycin.Cancer, 53, 199 (1984).
Hiraoka, M., Shiken, J., Dodo, Y., Ono, K., Takahashi, M., Nishida, H., Abe, M.: Clinical results of radiofrequency hyperthermia combined with radiation in the treatment of radioresistant cancers.Cancer, 54, 2898 (1984).
Herman, T. S., Teicher, B. A., Jochelson, M., Clark, J., Svensson, G., Coleman, C. N.: Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies.Int. J. Hyperthermia, 4, 143, (1988)
Cockett, A. T. K., Kazmin, M., Nakamura, R., Fingerhut, A., Stein, J. J.: Enhancement of regional megavoltage irradiation in bladder cancer using local bladder hyperthermia.J. Urol., 97, 1034 (1967).
Ohno, R., Kimura, K., Amaki, I., Hirano, M., Hoshino, A., Ikeda, Y., Ikeda, Y., Kimura, I., Kobayashi, M., Konno, K., Majima, H., Masaoka, T., Mizuno, H., Ogawa, M., Oguro, M., Saito, T., Shimoyama, M., Shirakawa, S., Sugawara, Y., Takaku, F., Yamada, H., Yamada, K., Yamagata, K., Yoshida, Y., Wakui, A.: Treatment of acute leukemia and malignant lymphoma with (2″R)-4′-O-tetrahydropyranyl-adriamycin.Cancer Chemother. Pharmacol., 20, 230 (1987).
Matsuda, T., Sugiyama, A., Nakada, Y.: Studies of radiofrequency hyperthermia (First report). Fundamental studies of Thermotron hyperthermia.J. Jpn. Soc. Cancer Ther., 18, 1904 (1983).
Abe, M., Hiraoka, M., Takahashi, M., Egawa, S., Matsuda, C., Onoyama, Y., Morita, K., Kakehi, M., Sugahara, T.: Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy.Cancer, 58, 1589 (1986).
Wong, K.-H., Maezawa, H., Urano, M.: Comparative study of thermoradiosensitization by misonidazole and metronidazolein vivo: Antitumour effect and pharmacokineticsInt. J. Hyperthermia, 8, 645 (1992).
Engin, K., Tupchong, L., Waterman, F. M., Nerlinger, R. T., Hoh, L. L., McFarlene, J. D., Leeper, D.B.: Thermoradiation with combined interstitial and external hyperthermia in advanced tumours in the head and neck with depth ≥3 cmInt. J. Hyperthermia, 9, 645 (1993).
You, Q.-S., Wang, R.-Z., Suen, G.-Q., Yan, F.-C., Gao, Y.-J., Cui, S.-R., Zhao, J.-H., Zhao, T.-Z., Ding, L.: Combination preoperative radiation and endocavity hyperthermia for rectal cancer: long-term results of 44 patients.Int. J. Hyperthermia, 9, 19 (1993).
Uchibayashi, T., Hisazumi, H., Kunimi, K., Hasegawa, T., Endo, Y., Noguchi, M., Sasaki, T.: Specific detection of metastasized human tumour cells in embryonic chicks by the polymerase chain reaction. In: Olsson, C. A. (ed.). Churchill Livingstone, London 1992.
Uchibayashi, T., Nakajima, K., Hisazumi, H., Mihara, S., Yamamoto, H., Koshida, K.: Studies of temperature rise in bladder cancer and surrounding tissues during radiofrequency hyperthermia.Eur. Urol., 21, 299 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uchibayashi, T., Yamamoto, H., Kunimi, K. et al. Radiofrequency capacitive hyperthermia combined with irradiation of chemotherapy for patients with invasive bladder cancers. International Urology and Nephrology 27, 735–741 (1995). https://doi.org/10.1007/BF02552139
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02552139